Deutsche Bank AG decreased its position in shares of CME Group Inc. (NASDAQ:CME) by 7.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,183,133 shares of the financial services provider’s stock after selling 96,451 shares during the period. Deutsche Bank AG owned 0.33% of CME Group worth $251,627,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in CME. The PNC Financial Services Group Inc. lifted its position in shares of CME Group by 3.5% in the first quarter. The PNC Financial Services Group Inc. now owns 66,692 shares of the financial services provider’s stock worth $13,620,000 after buying an additional 2,225 shares during the last quarter. D.A. Davidson & CO. lifted its position in shares of CME Group by 5.6% in the first quarter. D.A. Davidson & CO. now owns 23,558 shares of the financial services provider’s stock worth $4,811,000 after buying an additional 1,246 shares during the last quarter. Meridian Wealth Management LLC lifted its position in shares of CME Group by 72.1% in the first quarter. Meridian Wealth Management LLC now owns 4,107 shares of the financial services provider’s stock worth $839,000 after buying an additional 1,721 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its position in shares of CME Group by 34.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 36,188 shares of the financial services provider’s stock worth $7,391,000 after buying an additional 9,213 shares during the last quarter. Finally, PAX Financial Group LLC lifted its position in shares of CME Group by 6.3% in the first quarter. PAX Financial Group LLC now owns 2,988 shares of the financial services provider’s stock worth $610,000 after buying an additional 177 shares during the last quarter. 86.19% of the stock is owned by institutional investors.
In other news, insider Sean Tully sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 24th. The stock was sold at an average price of $200.20, for a total value of $1,001,000.00. Following the transaction, the insider now directly owns 23,479 shares of the company’s stock, valued at approximately $4,700,495.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, August 30th. The stock was sold at an average price of $201.00, for a total value of $201,000.00. Following the completion of the transaction, the director now directly owns 27,368 shares in the company, valued at $5,500,968. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,000 shares of company stock worth $1,786,150. Corporate insiders own 0.30% of the company’s stock.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 28th. The financial services provider reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.59 by $0.05. CME Group had a return on equity of 8.33% and a net margin of 41.64%. The company had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.17 billion. Sell-side analysts forecast that CME Group Inc. will post 6.65 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 27th. Stockholders of record on Friday, September 10th will be paid a $0.90 dividend. The ex-dividend date of this dividend is Thursday, September 9th. This represents a $3.60 annualized dividend and a dividend yield of 1.94%. CME Group’s dividend payout ratio is currently 53.57%.
A number of brokerages have weighed in on CME. TheStreet cut CME Group from a “b” rating to a “c+” rating in a research report on Wednesday, August 18th. Berenberg Bank reiterated a “hold” rating on shares of CME Group in a research note on Wednesday, September 15th. Atlantic Securities upgraded CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 price objective on the stock in a research note on Tuesday, September 14th. Finally, Morgan Stanley lifted their price objective on CME Group from $228.00 to $229.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 1st. One analyst has rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $210.83.
About CME Group
CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.
Read More: What are high-yield dividend stocks?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.